What is the pathogenesis of pulmonary hypertension?

 Pathogenesis of Pulmonary Hypertension

Pulmonary hypertension (PH) is a condition marked by increased pulmonary artery pressure due to narrowing, obstruction, or remodeling of the pulmonary vasculature. The pathogenesis is multifactorial, involving endothelial dysfunction, vasoconstriction, vascular remodeling, inflammation, and sometimes genetic mutations.

Step-by-Step Pathogenesis

1. Endothelial Cell Dysfunction

  • The initial trigger may be hypoxia, inflammation, mechanical stress, or toxins.

  • Leads to:

    • Vasodilators: nitric oxide (NO), prostacyclin (PGI₂)

    • Vasoconstrictors: endothelin-1, thromboxane A₂

  • Result: Persistent pulmonary vasoconstriction

2. Vascular Remodeling

  • Structural changes in pulmonary arteries:

    • Intimal fibrosis (scarring of the inner vessel layer)

    • Smooth muscle hypertrophy and hyperplasia (in the media)

    • Adventitial thickening

  • These changes cause narrowing and stiffening of pulmonary arteries → ↑ resistance.

3. Inflammation

  • Inflammatory cells (T-lymphocytes, macrophages, mast cells) infiltrate the vessel walls.

  • Release cytokines (e.g., IL-6, TNF-α) and growth factors (PDGF, VEGF).

  • Stimulates further cell proliferation and vascular remodeling.

4. Thrombosis in Situ

  • Endothelial injury makes the vessels pro-thrombotic.

  • Local formation of microthrombi in small pulmonary arteries.

  • Causes further occlusion and increased resistance.

5. Genetic Predisposition

  • Especially in idiopathic or familial cases (Group 1 PAH).

  • Mutation in BMPR2 gene (Bone Morphogenetic Protein Receptor Type 2):

    • Leads to unregulated smooth muscle proliferation

    • Impairs apoptosis (cell death)

6. Right Ventricular Hypertrophy and Failure

  • The right ventricle works harder to pump against high resistance.

  • Leads to:

    • Right ventricular hypertrophy

    • Eventually right-sided heart failure (cor pulmonale)

Simplified Flowchart

Endothelial Dysfunction
     ↓
Vasoconstriction + ↓ NO & PGI2 + ↑ Endothelin-1
     ↓
Vascular Remodeling (thickened walls, narrowed lumen)
     ↓
Increased Pulmonary Vascular Resistance
     ↓
Increased Pulmonary Artery Pressure (PH)
     ↓
Right Ventricular Hypertrophy → Right Heart Failure

Key Mechanisms Summary Table

Mechanism Effect
Endothelial dysfunction Imbalance of vasodilators and vasoconstrictors
Vasoconstriction Increased resistance in pulmonary arteries
Vascular remodeling Structural narrowing of arteries
Inflammation Promotes proliferation and fibrosis
Thrombosis in situ Further blocks blood flow
Genetic mutations (e.g., BMPR2) Promote abnormal cell growth & survival


Comments

Popular posts from this blog

What is a dpt program?

What is osteogenesis imperfecta?

what is brain encephalitis?